Biotech Investors & VC Firms in New York City
11 firms in this list, with a median first check of $500K. 2 of them lead rounds. Generated from verified public data and updated continuously.
Lux Capital
New YorkPre-Seed–Growth$100K – $100M
48 people
Deerfield Management Company
New YorkGrowth–Late Stage
88 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
41 people
Able Partners
New York CitySeed–Series A$500K – $3M
3 people
Partnership Fund for NYC
New York CitySeed–Growth
13 people
Easton Capital
New YorkSeed–Late Stage$10M – $20M
7 people
Access Biotechnology
New York CitySeed–Late Stage
2 people
Legendary Ventures, Llc.
New York CitySeed–Late Stage
6 people
Seldor Capital
New York CitySeed–Series A
4 people
Syno Capital, LLC
New YorkSeries A
4 people
Interlagos
New York City
2 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.



















